PAVMW Projected Dividend Yield
PAVmed Inc ( NASDAQ : PAVMW )PAVmed is a medical device company. Co.'s products include: EsoGuard, a molecular diagnostic esophageal DNA test shown in a published human study at detecting Barrett's Esophagus (BE), as well as adenocarcinoma of the esophagus (EAC); EsoCheck, a non-invasive cell collection device designed to sample cells from a targeted region of the esophagus; EsoCure, which is in development to provide an Esophageal Ablation Device using Caldus Technology to allow a clinician to treat dysplastic BE before it can progress to EAC; CarpX, a minimally invasive device designed to treat carpal tunnel syndrome; and NextFlo, an intravenous infusion set to eliminate the need for electronic infusion pumps. 20 YEAR PERFORMANCE RESULTS |
PAVMW Dividend History Detail PAVMW Dividend News PAVMW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |